{"mainPropery":{"diseaseId":12977,"diseaseName":"Mendelian susceptibility to mycobacterial diseases","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/12977/mendelian-susceptibility-to-mycobacterial-diseases","synonyms":["Idiopathic infection caused by BCG or atypical mycobacteria","Mendelian susceptibility to atypical mycobacteria","Mendelian susceptibility to mycobacterial diseases","Mendelian susceptibility to mycobacterial infections","MSMD"],"synonyms-with-source":[{"name":"Idiopathic infection caused by BCG or atypical mycobacteria","source":"OrphaData.Org"},{"name":"Mendelian susceptibility to atypical mycobacteria","source":"OrphaData.Org"},{"name":"Mendelian susceptibility to mycobacterial diseases","source":"OrphaData.Org"},{"name":"Mendelian susceptibility to mycobacterial infections","source":"OrphaData.Org"},{"name":"MSMD","source":"OrphaData.Org"}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"748"}]},"diseaseCategories":[],"organizations":[],"resource descriptions":[{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=748' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":10421,"questionText":"What is mendelian susceptibily to mycobacterial diseases?","answerText":"<strong>Mendelian susceptibility to mycobacterial diseases</strong> (MSMD) is a rare <a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/000818.htm\" target=\"_blank\">immunodeficiency syndrome</a>, with susceptibility to mycobacteria, such as the vaccine against <a href=\"http://www.cdc.gov/tb/topic/vaccines/default.htm\" target=\"_blank\">tuberculosis</a> (bacillus <a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a682809.html\" target=\"_blank\">Calmette-Gu&eacute;rin (BCG)</a>&nbsp;and <a href=\"http://www.lung.org/lung-health-and-diseases/lung-disease-lookup/nontuberculosis-mycobacteria/learn-about-ntm.html?referrer=https://www.google.com/\" target=\"_blank\">environmental mycobacteria</a>. It is&nbsp;characterized by severe, recurrent infections, either systemic (widespread) or localized. It has many subtypes.  The most serious types are the <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>  complete interferon gamma receptor 1 (IFN-gammaR1) and receptor 2 (IFN-gammaR2) deficiencies. MSMD due to partial IFN-gammaR1, partial IFN-gammaR2, complete IL-12R-beta1, complete IL12B, complete ISG15, partial STAT1 and partial IRF8 deficiencies and MSMD due to partial <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002051.htm\" target=\"_blank\">X-linked recessive</a>  (XR) mutations are less severe subtypes. Only about half of patients with MSMD have an identified genetic cause. Nine <a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">genes</a> are known to be responsible for MSMD. Seven of them are inherited in an autosomal recessive or <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a>  pattern (<em>IFNGR1, IFNGR2, STAT1, IL12B, IL12RB1, IRF8</em> and I<em>SG15</em> genes) and 2 are <a href=\"http://www.genome.gov/Glossary/index.cfm?id=209\" target=\"_blank\">X-linked</a>  (<em>IKBKG</em> and <em>CYBB</em> genes). BCG vaccination should be avoided in those with MSMD.  Treatment includes antibiotics and surgery for lymph node removal in some cases. <a href=\"http://www.cancer.gov/types/childhood-cancers/child-hct-hp-pdq\" target=\"_blank\">Hematopoietic stem cell transplantation</a> (HSCT) may be considered in specific cases. Prognosis depends on the specific <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a> and the associated disorder.[11112][11113]&nbsp;<span style=\"font-size: 9pt;\"><span style=\"font-size: 12pt;\"></span><br />\r\n<br />\r\n<br />\r\n</span>\r\n<ul>\r\n</ul>","dateModified":"2016-03-31T21:09:00"},"basicQuestions":[],"references":[],"relatedDiseases":[{"relatedDiseaseId":10934,"relatedDiseaseName":"Dendritic cell, monocyte, B lymphocyte, and natural killer lymphocyte deficiency","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":12976,"relatedDiseaseName":"IL12B deficiency","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":10984,"relatedDiseaseName":"IL12RB1 deficiency","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":3011,"relatedDiseaseName":"Interferon gamma, receptor 1, deficiency","relation":"Child","isRare":true,"hasGardPage":true}],"gardCases":[{"caseId":56243,"abbreviatedInquiry":"How might mendelian susceptibility to mycobacterial diseases be classified?","caseQuestions":[{"questionId":10445,"questionText":"How might mendelian susceptibility to mycobacterial diseases be classified?","answerText":"MSMD is classified into the following subtypes:[11112]\r\n<span style=\"font-size: 9pt; font-family: Verdana;\"><br />\r\n</span>\r\n<ul>\r\n    <li>Interferon-Gamma receptor deficiencies:</li>\r\n</ul>\r\n<ul style=\"margin-left: 40px;\">\r\n    <li><a href=\"http://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&amp;data_id=14471\" target=\"_blank\">Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR1 deficiency</a></li>\r\n    <li><a href=\"http://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&amp;data_id=21671\" target=\"_blank\">Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency</a></li>\r\n    <li><a href=\"http://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&amp;data_id=21677\" target=\"_blank\">Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency</a></li>\r\n    <li><a href=\"http://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&amp;data_id=21678\" target=\"_blank\">Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency</a></li>\r\n    <li><a href=\"http://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&amp;data_id=21675\" target=\"_blank\">Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency</a></li>\r\n    <li><a href=\"http://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&amp;data_id=21676\" target=\"_blank\">Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency</a><span style=\"font-size: 9pt; font-family: Verdana;\"><a href=\"http://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&amp;data_id=21676\" target=\"_blank\"></a>.</span></li>\r\n</ul>\r\n<ul>\r\n    <li><a href=\"http://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&amp;data_id=21672\" target=\"_blank\">I</a><a href=\"http://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&amp;data_id=21672\" target=\"_blank\">L-12 receptor Beta1 deficiency</a></li>\r\n    <li><a href=\"http://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&amp;data_id=21673\" target=\"_blank\">IL-12 p40 deficiency</a></li>\r\n    <li>STAT1 deficiency:&nbsp;</li>\r\n</ul>\r\n<ul style=\"margin-left: 40px;\">\r\n    <li><a href=\"http://omim.org/entry/613796\" target=\"_blank\">Autosomal recessive STAT1 deficiency</a>&nbsp;</li>\r\n    <li><a href=\"http://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&amp;data_id=21679\" target=\"_blank\">Autosomal dominant STAT1 deficiency</a></li>\r\n</ul>\r\n<ul>\r\n    <li><a href=\"http://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&amp;data_id=21680\" target=\"_blank\">IRF8 deficiency</a></li>\r\n    <li><a href=\"https://rarediseases.info.nih.gov/gard/10934/dendritic-cell-monocyte-b-lymphocyte-and-natural-killer-lymphocyte-deficiency/resources/1\" target=\"_blank\">GATA2 deficiency (MonoMAC SYNDROME)</a></li>\r\n    <li><a href=\"http://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&amp;data_id=21674\" target=\"_blank\">ISG15 deficiency</a></li>\r\n    <li><a href=\"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=319605\" target=\"_blank\">X-linked mendelian susceptibility to mycobacterial diseases</a>.</li>\r\n</ul>","dateModified":"2016-04-06T09:46:00","references":[{"referenceId":11112,"authors":"","articleTitle":"Mendelian susceptibility to mycobacterial diseases: Specific defects","bookWebsiteJournalTitle":"UpToDate","date":"April 17, 2015","volume":"","pages":"","url":"http://www.uptodate.com/contents/mendelian-susceptibility-to-mycobacterial-diseases-specific-defects","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"Mendelian_susceptibility_to_mycobacterial_diseases"}